海正药业：2月5日召开董事会会议

Group 1 - The company, Haizheng Pharmaceutical, announced that its 13th meeting of the 10th board of directors was held on February 5, 2026, via telecommunication [1] - The meeting reviewed a proposal regarding the adjustment of the repurchase price of restricted stock and the cancellation of certain restricted stocks granted to incentive recipients that have not yet been released from the lock-up period [1]